Is CASI Pharmaceuticals, Inc. CASI stock halal to invest in?

No, as of February 2026, CASI Pharmaceuticals, Inc. stock (CASI) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. CASI Pharmaceuticals, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for CASI Pharmaceuticals, Inc. and alternative halal stock options within the Tabadulat app.

How often is CASI Pharmaceuticals, Inc. CASI reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on CASI Pharmaceuticals, Inc. CASI monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does CASI Pharmaceuticals, Inc. CASI pass the AAOIFI Non Permissible Income criteria?

Yes, as of February 2026, CASI Pharmaceuticals, Inc. stock (CASI) passes the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources, such as interest, is below the acceptable threshold set by AAOIFI.

Does CASI Pharmaceuticals, Inc. CASI pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, CASI Pharmaceuticals, Inc. stock (CASI) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

No, as of February 2026, CASI Pharmaceuticals, Inc. stock (CASI) does not pass the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

CASI Pharmaceuticals, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

CASI

About

CASI Pharmaceuticals, Inc.

CASI

Casi Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics in the treatment of various types of cancer. The company's primary aim is to address the unmet clinical needs within the oncology sector, bringing advanced and effective treatment options to patients globally. Casi Pharmaceuticals Inc. leverages its strategic partnerships and distribution networks primarily across the North American and Asian markets, facilitating the development and delivery of their therapies. The company engages in late-stage clinical trials and regulatory approvals, with a focus on expanding its product pipeline through both in-house developments and strategic acquisitions. With a commitment to enhancing therapeutic efficacy and patient outcomes, Casi Pharmaceuticals Inc. plays a significant role in pioneering cancer treatment solutions, contributing to advancements in the healthcare and life sciences industries.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

233

Website:

https://www.casipharmaceuticals.com

CASI

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

CASI Pharmaceuticals, Inc.

About

CASI Pharmaceuticals, Inc.

CASI

Frequently asked questions

Is CASI Pharmaceuticals, Inc. CASI stock halal to invest in?

How often is CASI Pharmaceuticals, Inc. CASI reviewed for Shariah compliance?

Does CASI Pharmaceuticals, Inc. CASI pass the AAOIFI Non Permissible Income criteria?

Does CASI Pharmaceuticals, Inc. CASI pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy CASI Pharmaceuticals, Inc. CASI stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.